438 related articles for article (PubMed ID: 32804127)
1. Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
Parker AF; Smart CM; Scarapicchia V; Gawryluk JR;
J Alzheimers Dis; 2020; 77(3):1067-1076. PubMed ID: 32804127
[TBL] [Abstract][Full Text] [Related]
2. Structural neuroimaging changes associated with subjective cognitive decline from a clinical sample.
Riverol M; Ríos-Rivera MM; Imaz-Aguayo L; Solis-Barquero SM; Arrondo C; Montoya-Murillo G; Villino-Rodríguez R; García-Eulate R; Domínguez P; Fernández-Seara MA
Neuroimage Clin; 2024; 42():103615. PubMed ID: 38749146
[TBL] [Abstract][Full Text] [Related]
3. The compensatory phenomenon of the functional connectome related to pathological biomarkers in individuals with subjective cognitive decline.
Chen H; Sheng X; Luo C; Qin R; Ye Q; Zhao H; Xu Y; Bai F;
Transl Neurodegener; 2020 May; 9(1):21. PubMed ID: 32460888
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.
Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y
Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744
[TBL] [Abstract][Full Text] [Related]
5. Functional Connectivity Between the Posterior Default Mode Network and Parahippocampal Gyrus Is Disrupted in Older Adults with Subjective Cognitive Decline and Correlates with Subjective Memory Ability.
Sharma N; Murari G; Vandermorris S; Verhoeff NPLG; Herrmann N; Chen JJ; Mah L
J Alzheimers Dis; 2021; 82(1):435-445. PubMed ID: 34024823
[TBL] [Abstract][Full Text] [Related]
6. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
[TBL] [Abstract][Full Text] [Related]
7. Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.
Yan T; Wang Y; Weng Z; Du W; Liu T; Chen D; Li X; Wu J; Han Y
J Alzheimers Dis; 2019; 68(3):1013-1027. PubMed ID: 30958352
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity neuroimaging biomarkers for the identification of amnestic mild cognitive impairment based on resting-state fMRI and a triple network model.
Yu E; Liao Z; Tan Y; Qiu Y; Zhu J; Han Z; Wang J; Wang X; Wang H; Chen Y; Zhang Q; Li Y; Mao D; Ding Z
Brain Imaging Behav; 2019 Feb; 13(1):1-14. PubMed ID: 28466439
[TBL] [Abstract][Full Text] [Related]
10. Exploring Structural and Functional Brain Changes in Mild Cognitive Impairment: A Whole Brain ALE Meta-Analysis for Multimodal MRI.
Gu L; Zhang Z
ACS Chem Neurosci; 2019 Jun; 10(6):2823-2829. PubMed ID: 30808171
[TBL] [Abstract][Full Text] [Related]
11. Differential medial temporal lobe and default-mode network functional connectivity and morphometric changes in Alzheimer's disease.
Grajski KA; Bressler SL;
Neuroimage Clin; 2019; 23():101860. PubMed ID: 31158694
[TBL] [Abstract][Full Text] [Related]
12. Changes in thalamic connectivity in the early and late stages of amnestic mild cognitive impairment: a resting-state functional magnetic resonance study from ADNI.
Cai S; Huang L; Zou J; Jing L; Zhai B; Ji G; von Deneen KM; Ren J; Ren A;
PLoS One; 2015; 10(2):e0115573. PubMed ID: 25679386
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Early Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Healthy Elderly Samples Using Multimodal Neuroimaging Indices.
Joshi H; Bharath S; Balachandar R; Sadanand S; Vishwakarma HV; Aiyappan S; Saini J; Kumar KJ; John JP; Varghese M
Brain Connect; 2019 Nov; 9(9):730-741. PubMed ID: 31389245
[TBL] [Abstract][Full Text] [Related]
14. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Connectivity in Mild Cognitive Impairment and Alzheimer Disease Revealed by Multimodal Neuroimaging Data.
Li Q; Wu X; Xie F; Chen K; Yao L; Zhang J; Guo X; Li R;
Neurodegener Dis; 2018; 18(1):5-18. PubMed ID: 29334684
[TBL] [Abstract][Full Text] [Related]
16. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
17. Interhemispheric functional connectivity for Alzheimer's disease and amnestic mild cognitive impairment based on the triple network model.
Liao ZL; Tan YF; Qiu YJ; Zhu JP; Chen Y; Lin SS; Wu MH; Mao YP; Hu JJ; Ding ZX; Yu EY
J Zhejiang Univ Sci B; 2018 Dec.; 19(12):924-934. PubMed ID: 30507076
[TBL] [Abstract][Full Text] [Related]
18. A novel joint HCPMMP method for automatically classifying Alzheimer's and different stage MCI patients.
Sheng J; Wang B; Zhang Q; Liu Q; Ma Y; Liu W; Shao M; Chen B
Behav Brain Res; 2019 Jun; 365():210-221. PubMed ID: 30836158
[TBL] [Abstract][Full Text] [Related]
19. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
[TBL] [Abstract][Full Text] [Related]
20. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
Moreno-Grau S; Rodríguez-Gómez O; Sanabria Á; Pérez-Cordón A; Sánchez-Ruiz D; Abdelnour C; Valero S; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Lafuente A; Gil S; Santos-Santos MÁ; Alegret M; Espinosa A; Ortega G; Guitart M; Gailhajanet A; de Rojas I; Sotolongo-Grau Ó; Ruiz S; Aguilera N; Papasey J; Martín E; Peleja E; ; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MÁ; Giménez J; Serrano-Ríos M; Orellana A; Tárraga L; Ruiz A; Boada M;
Alzheimers Dement; 2018 May; 14(5):634-643. PubMed ID: 29156223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
